Foster Group
GILD icon

Foster Group’s Gilead Sciences GILD Stock Holding History

Foster Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$354K Buy
2,377
+187
+9% +$26.2K 0.01% 221
2026
Q2 		$277K Sell
2,190
-125
-5% -$16.5K 0.01% 256
2026
Q1 		$323K Buy
2,315
+290
+14% +$40.6K 0.01% 204
2025
Q4 		$249K Buy
2,025
+116
+6% +$14.1K 0.01% 243
2025
Q3 		$212K Buy
1,909
+43
+2% +$4.89K 0.01% 252
2025
Q2 		$207K Buy
+1,866
New +$199K 0.01% 248

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Foster Group's GILD Position: Q3 2026 in Review

Foster Group increased its Gilead Sciences (GILD) stake by 8.5% in Q3 2026, buying an estimated $26.2K and bringing the position to 2,377 shares worth $354K. The position accounts for 0.01% of the portfolio, ranked #221.

Foster Group first reported a position in GILD in Q2 2025 and has held it in 6 quarters since. 488 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Foster Group held 2,377 shares of Gilead Sciences worth $354K as of Q3 2026.
  • Foster Group bought 187 Gilead Sciences shares in Q3 2026, an estimated $26.2K.
  • Gilead Sciences made up 0.01% of Foster Group's portfolio in Q3 2026, its #221 holding.
  • Foster Group first reported a position in Gilead Sciences in Q2 2025 and has held it in 6 quarters since.
  • 488 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Foster Group's 13F filing for Q3 2026, filed 13 Oct 2026.